Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004284-21Phase 4Completed
Phase 4, randomised trial of cefazolin in Infection (2 arms), sponsored by Policlinico Gemelli. Primary endpoints: Incidence of infections, Toxicity and 3 more. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004284-21.